Bio-MEMS eye sensor for continuous monitoring of intraocular pressure

用于持续监测眼压的生物 MEMS 眼传感器

• 批准号: LP0669838
• 负责人: Dr Jamie Craig
• 金额: $ 9.29万
• 依托单位: Flinders University
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2007
• 资助国家: 澳大利亚
• 起止时间: 2007-06-30 至 2011-08-17
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP0669838
• 关键词: Bio; MEMS; eye; sensor; continuous

Glaucoma is a leading cause of preventable blindness, particularly prevalent in the 60+ population, caused by elevated intraocular pressure (IOP). Current treatment to monitor and prevent glaucoma-related blindness is by lowering IOP with eye-drops, laser therapy or surgery. This project directly benefits our aging population by ensuring independence and quality of life, whilst reducing long-term medical and social costs. By incorporating nanotechnology with ophthalmology we will provide an economic solution to long-term, reliable, home-monitoring of IOP. An implantable IOP sensor, will identify patients requiring more invasive treatment compared with those with less aggressive disease, leading to better health resource utilisation.

青光眼是由眼内压（IOP）升高引起的可预防性失明的主要原因，在60岁以上人群中尤其普遍。目前监测和预防青光眼相关失明的治疗方法是通过滴眼液、激光治疗或手术降低IOP。该项目通过确保独立性和生活质量，同时降低长期医疗和社会成本，直接造福于我们的老龄化人口。通过将纳米技术与眼科学相结合，我们将为长期、可靠的家庭眼压监测提供一种经济的解决方案。植入式IOP传感器将识别需要更多侵入性治疗的患者，而不是侵袭性较低的患者，从而更好地利用卫生资源。